Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition Background: Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by the hallmark finding of cerebral amyloid deposition. Many researchers have tried to predict the existence of cerebral amyloid deposition by using easily accessible blood plasma samples, but the effectiveness of such strategies… Continue reading
